Leading life sciences developers have hailed the UK’s return to the £85bn Horizon Europe research scheme as a major opportunity to rekindle stalled or withdrawn funding for projects in the sector. Experts also predicted that rejoining the science programme will
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.
Register
Find Out More